NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study

Authors:

Abstract
Background: Blood neurofilament light chain (NfL) is increasingly considered as a key trial biomarker in genetic frontotemporal dementia (gFTD). We aimed to facilitate the use of NfL in gFTD multicentre trials by testing its (1) reliability across labs; (2) reliability to stratify gFTD disease stages; (3) comparability between blood matrices and (4) stability across recruiting sites.Methods: Comparative analysis of blood NfL levels in a large gFTD cohort (GENFI) for (1)–(4), with n=344 samples (n=148 presymptomatic, n=11 converter, n=46 symptomatic subjects, with mutations inC9orf72,GRNorMAPT; and n=139 within-family controls), each measured in three different international labs by Simoa HD-1 analyzer.Results: NfL revealed an excellent consistency (intraclass correlation coefficient (ICC) 0.964) and high reliability across the three labs (maximal bias (pg/mL) in Bland-Altman analysis: 1.12±1.20). High concordance of NfL across laboratories was moreover reflected by high areas under the curve for discriminating conversion stage against the (non-converting) presymptomatic stage across all three labs. Serum and plasma NfL were largely comparable (ICC 0.967). The robustness of NfL across 13 recruiting sites was demonstrated by a linear mixed effect model.Conclusions: Our results underline the suitability of blood NfL in gFTD multicentre trials, including cross-lab reliable stratification of the highly trial-relevant conversion stage, matrix comparability and cross-site robustness.
Funding Information
  • Miriam Marks Brain Research UK Senior Fellowship (N/A)
  • European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement (860197 (MIRIADE))
  • Alzheimer Nederland (N/A)
  • ZonMw Memorable (733 051 042)
  • MRC Clinician Scientist Fellowship (MR/M008525/1)
  • National Institute for Health and Care Research University College London Hospitals Biomedical Research Centre (N/A)
  • Deutsche Forschungsgemeinschaft German Research Foundation under Germany’s Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy—ID 390857198)
  • Bluefield project (N/A)
  • Association for Frontotemporal Dementias Research Grant (2009)
  • Alzheimer's Association (ADSF-21-831376-C, ADSF-21-831377-C, ADSF-21-831381-C)
  • Alzheimer Drug Discovery Foundation (ADDF), USA (201809-2016862)
  • Germany's Federal Ministry of Education and Research (N/A)
  • European Reference Network for Rare Neurological Diseases (739510)
  • Tau Consortium (N/A)
  • Mady Browaeys Fund for Research into Frontotemporal Dementia (N/A)
  • National Institute for Health Research Cambridge Biomedical Research Centre (BRC-1215-20014)
  • Erling-Persson Family Foundation (N/A)
  • Olav Thon Foundation (N/A)
  • Medical Research Council (SUAG/051 G101400)
  • Ontario Brain Institute (N/A)
  • Weston Brain Institute (N/A)
  • Dioraphte Foundation (09-02-03-00)
  • Canadian Institute of Health Research (327387)
  • AD strategic fund (N/A)
  • Cambridge University Centre for Frontotemporal Dementia (N/A)
  • Brain Foundation (N/A)
  • Alzheimer Foundation (N/A)
  • Swedish FTD Inititative-Schörling Foundation (N/A)
  • Stiftelsen för Gamla Tjänarinnor, Hjärnfonden, Sweden (FO2022-0270)
  • European Union Joint Programme – Neurodegenerative Disease Research (JPND2021-00694)
  • Swedish State Support for Clinical Research (ALFGBG-71320)
  • European Union’s Horizon Europe research and innovation programme (101053962)
  • Alzheimer’s Research UK Clinical Research Training Fellowship (ARUK-CRF2017B-2)
  • Center for Networked Biomedical Research on Neurodegenerative Disease (N/A)
  • EU Joint Programme - Neurodegenerative Disease Research Prefrontals (2018-02754, VR 2015-02926, VR Dnr 529-2014-7504)
  • Netherlands Organization for Scientific Research (HCMI 056-13-018)
  • Swedish Research Council (2019-02397, 2022-01018)
  • Else Kröner-Fresenius-Stiftung - Clinician Scientist programme "PRECISE.net" (N/A)
  • EU Joint Programme - Neurodegenerative Disease Research GENFI-PROX (2019-02248)
  • Italian Ministry of Health (733051042)
  • EU Joint Programme - Neurodegenerative Disease Research (N/A)
  • Fundación Marat de TV3, Spain (20143810)
  • Stockholm County Council ALF (N/A)
  • UK Dementia Research Institute at UCL (UKDRI-1003)
  • Wellcome Trust (103838)

This publication has 23 references indexed in Scilit: